Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine (2016)
Chapter: Appendix C: Information-Gathering Sessions and Speakers
Appendix C
Information-Gathering Sessions and Speakers
COMMITTEE MEETING 1 – JANUARY 29, 2015
JEFFREY S. DLOTT, Medical Director, Coagulation and Immunohematology, Quest Diagnostics
LEVI GARRAWAY, Associate Professor, Department of Medicine, Harvard Medical School
BRUCE G. HAFFTY, Chair of the Board, American Society for Radiation Oncology
STANLEY R. HAMILTON, College of American Pathologists
DANIEL F. HAYES, Clinical Director, Breast Oncology Program, University of Michigan Comprehensive Cancer Center
LOUIS JACQUES, Senior Vice President and Chief Clinical Officer, ADVI Consulting
LARRY NORTON, Founder and Scientific Director, Breast Cancer Research Foundation
KIRSTEN PAULSON, Senior Director, Research, Medical Device Development, Pfizer Inc.
RICHARD L. SCHILSKY, Chief Medical Officer, American Society of Clinical Oncology
COMMITTEE MEETING 2 – APRIL 1, 2015
SAMUEL ARONSON, Executive Director, IT, Partners Personalized Medicine
ROBERT CALIFF, Deputy Commissioner for Medical Products and Tobacco, Food and Drug Administration
BRIAN CAREY, Partner, Foley Hoag, LLP
JOSEPH CHIN, Senior Medical Advisor/Acting Deputy Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services
CURTIS HANSON, Professor of Laboratory Medicine and Pathology, Chief Medical Officer, Mayo Medical Laboratories, Mayo Clinic
JONATHAN W. HEUSEL, Chief Medical Officer, Genomics and Pathology Services and Medical Director of the Clinical Laboratory, The Genome Institute of Washington University, Washington University School of Medicine in St. Louis
ELIZABETH MANSFIELD, Deputy Office Director for Personalized Medicine, Office of In Vitro Diagnostics and Radiological Health/Center for Devices and Radiological Health, Food and Drug Administration
LAWRENCE J. MEYER, Professor of Dermatology and Internal Medicine, University of Utah Health Sciences Center; Associate Chief of Staff, Research, Salt Lake City Veterans Affairs Medical Center; and National Director, Genomic Medicine, Veterans Health Administration
LEE N. NEWCOMER, Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthCare
MARISA PAPALUCA, Senior Scientific Advisor, Human Medicines Research & Development Support Division, European Medicines Agency
SCOTT RAMSEY, Professor, School of Medicine, School of Pharmacy, and the Institute for Public Health Genetics, University of Washington
WILLIAM W. STEAD, Associate Vice Chancellor for Health Affairs; Chief Strategy Officer, McKesson Foundation Professor of Biomedical Informatics, Professor of Medicine, Vanderbilt University Medical Center
SUZANNE TOPALIAN, Professor of Surgery and Oncology, Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
JOHN A. WAGNER, Senior Vice President, Head of Clinical and Translational Sciences, Takeda Pharmaceuticals
SHEILA WALCOFF, CEO and Founder, Goldbug Strategies, LLC
MARC S. WILLIAMS, Director, Genomic Medicine Institute, Geisinger Health System
JANET WOODCOCK, Director, Center for Drug Evaluation and Research, Food and Drug Administration
COMMITTEE REIMBURSEMENT WEBINAR – MAY 4, 2015
ELAINE JETER, MolDx Medical Director, Palmetto GBA
ROBERT McDONOUGH, Head of Clinical Policy Research and Development, Aetna
LINCOLN NADAULD, Director, Cancer Genomics, Intermountain Healthcare
PAUL RADENSKY, Partner, McDermott, Will & Emery
ALAN ROSENBERG, Vice President, Medical and Clinical Pharmacy Policy, Anthem
COMMITTEE MEETING 3 – JUNE 11, 2015
STEPHEN FRIEND, President, Co-Founder, and Director, Sage Bionetworks
SARAH GARCIA, Clinical Genomics Applications Manager, Personalis, Inc.
CLIFFORD A. HUDIS, Chief, Breast Medicine Service, Memorial Sloan Kettering Cancer Center
ROBERT WILDIN, Chief, Genomic Healthcare Branch, National Human Genome Research Institute
This page intentionally left blank.
